Related Experiment Video
Updated: Jun 30, 2025
13:27
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
48.0K
Osteopathic manipulative treatment for chronic inflammatory diseases
Ross Gillan1, Gabrielle Bachtel1, Kassidy Webber1
1College of Osteopathic Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, Florida, USA.
Journal of Evidence-Based Medicine
|March 15, 2024
Summary
Osteopathic manipulative treatment (OMT) may offer anti-inflammatory benefits for chronic inflammatory diseases (CIDs). This review found variable patient outcomes when OMT was used to manage conditions like asthma and irritable bowel syndrome.
Area of Science:
- Integrative Medicine
- Rheumatology
- Pulmonology
Background:
- Chronic inflammatory diseases (CIDs) are widespread, debilitating conditions.
- Osteopathic manipulative treatment (OMT) is a manual therapy that supports the body's healing.
- OMT presents a potential anti-inflammatory approach for CID management.
Purpose of the Study:
- To objectively evaluate the therapeutic benefits of OMT in patients with CIDs.
- To review the efficacy of OMT in managing diverse chronic inflammatory conditions.
- To synthesize evidence on OMT's role in CID treatment.
Main Methods:
- A structured literature search was conducted.
- Studies on asthma, COPD, IBS, ankylosing spondylitis, and PAD were included.
- OMT modalities (lymphatic, Still, counterstrain, muscle energy) were analyzed against sham, routine care, or no treatment controls.
Main Results:
- Patient outcomes with OMT varied across different CIDs.
- The effectiveness of OMT was not uniform for all studied inflammatory conditions.
- Specific OMT techniques showed varied impacts on disease pathologies.
Conclusions:
- OMT demonstrates potential as an adjunctive therapy for CIDs.
- Further research is needed to clarify OMT's specific benefits for distinct CIDs.
- OMT's role in managing chronic inflammation requires more targeted investigation.
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
01:29Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118